Is Almirall SA halal to invest in?

As of August 2026, Almirall SA ALM.VI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Almirall SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Almirall SA using these criteria to determine its compliance status.

Can Muslims buy shares of Almirall SA?

Muslim investors may consider investing in Almirall SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Almirall SA classified as HALAL?

Musaffa determines the Shariah status of Almirall SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Almirall SA updated?

The Shariah compliance status of Almirall SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Almirall SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Almirall SA?

You can check the latest Shariah compliance status of Almirall SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Almirall SA ALM.VI

Last Updated: Aug 18, 12:00 AM·WBAG

ALM.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Almirall SA is classified as halal.

HALAL

Report Source: undefined Quarter Report

Almirall SA. Stock Analysis ALM.VI

Austria Health Care Mid Cap

Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company employs 2,108 full-time employees The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.